Gabapentin Tablet
Product Images NDC 63629-7308

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 63629-7308). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Equation (Equation)

An illustration showing the formula for calculating creatinine clearance (CLCr), which includes patient age, weight, serum creatinine levels, and a multiplication factor of 0.85 for female patients.*

FDA Label Image

Figure1 (Figure1)

A line graph depicting mean pain scores over an 8-week period for placebo and Gabapentin (3600 mg/day) groups. The x-axis represents weeks from baseline to week 8, including a 4-week dose titration and a 4-week fixed dose period. The y-axis shows mean pain scores from 0 to 10, with Gabapentin scores decreasing over time compared to placebo.*

FDA Label Image

Figure2 (Figure2)

Line graph showing mean pain scores over 7 weeks for three groups: placebo, gabapentin 1800 mg/day, and gabapentin 2400 mg/day. The x-axis represents weeks, including a 3-week dose titration period and a 4-week fixed dose period. The y-axis shows mean pain scores from 0 to 10. Gabapentin groups show decreasing pain scores compared to placebo over time.*

FDA Label Image

Figure3 (Figure3)

A bar chart titled 'Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies' comparing placebo (PBO) and Gabapentin (GBP) groups in two studies. Study 1 shows 12% response for placebo and 29% for GBP 3600 mg. Study 2 shows 14% for placebo, 32% for GBP 1800 mg, and 34% for GBP 2400 mg, with statistical significance noted at p < 0.01 and p < 0.001 levels.*

FDA Label Image

Figure4 (Figure4)

A graph showing dose-response data for Gabapentin across three studies labeled a, b, and c. The x-axis represents daily dose in milligrams ranging from 600 to 1800 mg, and the y-axis shows percent difference ranging from 2% to 22%. Data points are plotted for each study at various doses with notable differences for each study indicated by letters near the points.*

FDA Label Image

Glenmarklogo1 (Glenmarklogo1)

FDA Label Image

Glenmarklogo2 (Glenmarklogo2)

FDA Label Image

Label (Lbl636297308)

Gabapentin Tablets, USP 800 mg film-coated tablet label from Bryant Ranch Prepack. The label states the product contains 90 tablets, is Rx only, and is repackaged by Bryant Ranch Prepack, Inc., Burbank, CA. Manufactured by Glenmark Pharmaceuticals Limited. Storage and handling instructions and QR codes for package insert and prescribing information are also visible.*

FDA Label Image

Structure (Structure)

Chemical structure of Gabapentin, showing a cyclohexane ring attached to an amino group and a carboxylic acid group, illustrating the molecular arrangement of this active ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.